Not yet recruitingNCT07301099
Epidemiology and Current Practices in Severe Community-Acquired Pneumonia
Studying Syringocystadenoma papilliferum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidad de la Sabana
- Principal Investigator
- Luis Felipe Reyes, MD, MSc, PhDUniversidad de la Sabana
- Enrollment
- 2588 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Clínica Universidad de La Sabana, Chía, Colombia
Collaborators
International Severe Acute Respiratory and Emerging Infection Consortium · European Society of Intensive Care Medicine · Latin American Intensive Care Network (LIVEN)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07301099 on ClinicalTrials.govOther trials for Syringocystadenoma papilliferum
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07070284ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"Joan Sabater Riera
- RECRUITINGNANCT06877936Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)Ramsay Générale de Santé
- RECRUITINGPHASE3NCT05722938Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)Biotest